CAFs are also a source of glutamine in the TME so targeting glutamine synthetase (GLUL) in CAFs along with GS in cancer cells leads to synergistic effect which reduces metastatic potential of ovarian cancer (379). This evidence concerns the gene GLUL and ovarian carcinoma.